Streetbeat News

Price Targets

SBUX

Morgan Stanley upgraded Starbucks (NASDAQ:SBUX) to Overweight with a new price target of $120.00, up from $112.00. Starbucks shares are currently trading at $92.23, and the new target suggests a potential 30.11% increase. Starbucks operates over 38,000 stores globally and generates revenue through various segments including company-operated stores and product sales.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

COHR

Coherent (NYSE:COHR) received mixed analyst ratings over the past three months, with 3 bullish, 2 somewhat bullish, and 1 indifferent. The average 12-month price target is $49.33, up from $43.00, with a high of $60.00 and a low of $40.00. Analysts from Barclays, Raymond James, Needham, Morgan Stanley, and Benchmark have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Coherent operates in engineered materials and optoelectronics, facing challenges in revenue growth (-21.68% over 3 months) and below-average ROE and ROA, but with a strong net margin of -9.28% and a high debt-to-equity ratio of 0.92.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

BAC

Oppenheimer has maintained its Outperform rating for Bank of America (NYSE:BAC) but lowered its price target from $50.00 to $49.00. Bank of America's shares are currently trading at $32.50, down 0.91% over the last 24 hours. The new price target suggests a potential upside of 50.77% from the current share price. Bank of America is a major financial institution in the U.S., with over $2.5 trillion in assets and a focus on consumer banking, wealth and investment management, global banking, and global markets.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

ARM

ARM Holdings (NASDAQ:ARM) has been the subject of diverse analyst ratings over the past three months, with 6 analysts offering ratings ranging from bullish to indifferent. The average 12-month price target is $77.5, with a high of $110.00 and a low of $55.00, indicating an 8.77% increase from the previous average of $71.25. Analysts from firms including Keybanc, Mizuho, Rosenblatt, Deutsche Bank, Wells Fargo, and Morgan Stanley have adjusted their ratings and price targets, reflecting their views on ARM's market performance and financial indicators such as revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

LBPH

Cantor Fitzgerald has reaffirmed its Overweight rating on Longboard Pharmaceuticals (NASDAQ:LBPH) and increased its price target from $55.00 to $60.00. Despite a slight decline in share price over the last 24 hours, the new price target suggests a potential upside of 156.96% from the current price of $23.35. Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for neurological diseases, with a focus on selective G protein-coupled receptors (GPCRs).

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

VCEL

HC Wainwright & Co. has reaffirmed its Buy rating on Vericel (NASDAQ:VCEL) and increased its price target from $44.50 to $46.00. Vericel's shares are currently trading at $38.24, and the new price target suggests a potential upside of 20.29%. Vericel is a biopharmaceutical company focused on cell therapy products for sports medicine and severe burn care.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

JBHT

Raymond James has reaffirmed its Outperform rating on JB Hunt Transport Servs (NASDAQ:JBHT) and increased its price target from $200.00 to $209.00. JBHT's shares are currently trading up 2.57% at $197.01. The new price target suggests a potential upside of 6.09% from the current price. JB Hunt is a leading surface transportation company in North America, with various operating segments including intermodal delivery and dedicated trucking services.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

FRT

Truist Securities analyst Ki Bin Kim has upgraded Federal Realty Investment (NYSE:FRT) from Hold to Buy and set a price target of $117.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 4:58 pm

AMD

Barclays analyst Tom O'Malley has maintained an Overweight rating on Advanced Micro Devices (AMD) and increased the price target from $120 to $200. This reflects a positive outlook on AMD's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 4:57 pm

SANA

HC Wainwright & Co. analyst Emily Bodnar has upgraded Sana Biotechnology (NASDAQ:SANA) from Neutral to Buy and set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 4:56 pm